AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Path 7.5 Tablet

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Pioglitazone (7.5mg)

Overview Path 7.5 Tablet

Adults with type 2 diabetes mellitus may use Path 7.5 Tablets to manage their blood glucose. This medication helps regulate blood sugar, mitigating the risk of serious diabetic complications such as vision impairment and kidney disease. Path 7.5 Tablets can be prescribed alone or in conjunction with other treatments, and may be taken with or without food. Consistent daily dosing at the same time maximizes efficacy. Dosage adjustments are determined by your physician based on treatment response. Continued use, even with controlled blood sugar and well-being, is crucial. Discontinuing the medication without medical supervision can elevate blood sugar, increasing the risk of kidney damage, blindness, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include headache, sinus inflammation, myalgia, and sore throat. Persistent or bothersome side effects warrant medical consultation. This medication is contraindicated for individuals with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to commencing treatment, inform your physician of any history of cardiac disease, thyroid disorders, or endocrine imbalances; its suitability may be affected. Pregnant or lactating women should seek medical advice before initiating treatment. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to track blood cell counts and liver function.

Uses of Path 7.5 Tablet

Managing Type 2 Diabetes

Major Benefits of Path 7.5 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Path 7.5 Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Path 7.5 Tablet:

  • Headache
  • Sore throat
  • Sinus inflammation
  • Muscle pain

How to use Path 7.5 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Path 7.5 Tablets can be consumed with or without food, though consistent timing is recommended.

How Path 7.5 Tablet works:

Glycemia 7.5mg tablets are used to manage diabetes. Their mechanism of action involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Path 7.5 Tablet.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Path 7.5 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCAUTION

Administering Path 7.5 Tablet to breastfeeding mothers requires careful consideration. Discontinue breastfeeding until the mother's treatment concludes and the medication is fully cleared from her system. Closely observe the infant's blood glucose levels while the mother is taking Path 7.5 Tablet.

DrivingDrivingSAFE

Driving ability is typically unaffected by Path 7.5 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Individuals with kidney impairment may safely take Path 7.5 Tablet without any required alteration to the prescribed dosage.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Path 7.5 Tablet, as dose modification may be necessary. Consult a physician for guidance. Path 7.5 Tablet is contraindicated for patients exhibiting severe hepatic dysfunction.

What if you forget to take Path 7.5 Tablet :

Omit any missed Path 7.5 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.

Facts to Know About Path 7.5 Tablet

LabelValue
Chemical Type Thiazolidinedione-based compound
Developing Habits No.
Treatment Category Diabetes Management
Active Class PPARγ agonist (thiazolidinedione)

FAQs on Path 7.5 Tablet

Path 7.5 Tablet is often associated with weight gain, potentially linked to dosage. This gain may result from fat accumulation, although in patients with heart failure, fluid retention may be the primary cause. Close weight monitoring is crucial for heart failure patients taking this medication.
Path 7.5 Tablet may cause fluid retention, potentially worsening or accelerating heart failure. Treatment in patients with at least one heart failure risk factor (e.g., prior heart attack, coronary artery disease, advanced age) typically begins with the lowest dose, gradually increasing as tolerated. Concomitant use of Path 7.5 Tablet and insulin increases the risk of heart failure.
Yes, Path 7.5 Tablet can augment metformin treatment in adults with type 2 diabetes mellitus, particularly overweight individuals whose blood sugar remains poorly controlled despite metformin monotherapy.
Take Path 7.5 Tablet once daily, at the same time each day if possible, with or without food, as directed by your doctor.
Follow your doctor's instructions regarding Path 7.5 Tablet. Diabetes treatment often requires lifelong medication; if you need to discontinue use, consult your doctor for alternative options. Never stop taking this medication without medical advice, as doing so can dangerously raise your blood sugar.
Path 7.5 Tablet can raise liver enzyme levels; discontinue use if this occurs. Regular liver enzyme monitoring is necessary during treatment. This medication is contraindicated in patients with liver disease.
Path 7.5 Tablet, a thiazolidinedione, manages blood sugar by enhancing insulin sensitivity. This improves how your body utilizes insulin, making your cells more responsive.
Path 7.5 Tablet carries a very low risk of increasing bladder cancer risk. Seek immediate medical attention if you develop hematuria, dysuria, or urinary urgency while taking this medication. Patients with a history of bladder cancer should not use Path 7.5 Tablet.
Path 7.5 Tablet
78
MRP 95
17% off